• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Physiology. COX-2 inhibitors and cardiovascular risk.

作者信息

Cannon Christopher P, Cannon Paul J

机构信息

Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.

出版信息

Science. 2012 Jun 15;336(6087):1386-7. doi: 10.1126/science.1224398.

DOI:10.1126/science.1224398
PMID:22700906
Abstract
摘要

相似文献

1
Physiology. COX-2 inhibitors and cardiovascular risk.生理学。COX - 2抑制剂与心血管风险。
Science. 2012 Jun 15;336(6087):1386-7. doi: 10.1126/science.1224398.
2
COX-2 inhibitors and cardiovascular risk.环氧化酶-2抑制剂与心血管风险。
J Cardiovasc Pharmacol. 2007 Nov;50(5):470-9. doi: 10.1097/FJC.0b013e318157f72d.
3
Marked interindividual variability in the response to selective inhibitors of cyclooxygenase-2.环氧化酶-2选择性抑制剂反应存在显著个体间差异。
Gastroenterology. 2006 Jan;130(1):55-64. doi: 10.1053/j.gastro.2005.10.002.
4
[Innovation of anti-inflammatory drugs--inhibition of cyclooxygenases].[抗炎药物的创新——环氧化酶的抑制作用]
Yao Xue Xue Bao. 2005 Nov;40(11):967-9.
5
The pharmacology of selective inhibition of COX-2.COX-2选择性抑制的药理学
Thromb Haemost. 2006 Oct;96(4):393-400.
6
Stronger inhibition by nonsteroid anti-inflammatory drugs of cyclooxygenase-1 in endothelial cells than platelets offers an explanation for increased risk of thrombotic events.非甾体抗炎药对内皮细胞中环氧化酶-1的抑制作用强于对血小板的抑制作用，这为血栓形成事件风险增加提供了解释。
FASEB J. 2006 Dec;20(14):2468-75. doi: 10.1096/fj.06-6615com.
7
COX-2 inhibitors and the thrombotic risk.环氧化酶-2抑制剂与血栓形成风险
Thromb Haemost. 2006 Oct;96(4):391-2.
8
Pivotal role of protein kinase Cdelta in angiotensin II-induced endothelial cyclooxygenase-2 expression: a link to vascular inflammation.蛋白激酶 Cδ在血管紧张素Ⅱ诱导的内皮细胞环氧化酶-2 表达中的关键作用：与血管炎症的联系。
Arterioscler Thromb Vasc Biol. 2011 May;31(5):1169-76. doi: 10.1161/ATVBAHA.110.216044. Epub 2011 Feb 10.
9
Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk.环氧化酶-2抑制剂、非甾体抗炎药与心血管风险
Cardiol Clin. 2008 Nov;26(4):589-601. doi: 10.1016/j.ccl.2008.06.004.
10
The cycloxygenase 2 (COX-2) story: it's time to explain, not inflame.环氧化酶2（COX - 2）的故事：是时候解释清楚，而非煽动情绪了。
J Cardiovasc Pharmacol Ther. 2007 Jun;12(2):98-111. doi: 10.1177/1074248407301172.

引用本文的文献

1
Coronary Artery Disease Risk Variant Dampens the Expression of CALCRL by Reducing HSF Binding to Shear Stress Responsive Enhancer in Endothelial Cells In Vitro.冠心病风险变异体通过减少热休克因子与体外培养的内皮细胞中剪切应力反应增强子的结合来抑制CALCRL的表达。
Arterioscler Thromb Vasc Biol. 2024 Jun;44(6):1330-1345. doi: 10.1161/ATVBAHA.123.318964. Epub 2024 Apr 11.
2
Cardiovascular Safety of Celecoxib after Cardiac Surgery with Cardiopulmonary Bypass: A Retrospective Cohort Study.心脏搭桥手术后塞来昔布的心血管安全性：一项回顾性队列研究。
Ann Clin Epidemiol. 2021 Oct 1;3(4):101-108. doi: 10.37737/ace.3.4_101. eCollection 2021.
3
Combating pan-coronavirus infection by indomethacin through simultaneously inhibiting viral replication and inflammatory response.
吲哚美辛通过同时抑制病毒复制和炎症反应来对抗全冠状病毒感染。
iScience. 2023 Aug 16;26(9):107631. doi: 10.1016/j.isci.2023.107631. eCollection 2023 Sep 15.
4
Synthesis, Biological, Spectroscopic and Computational Investigations of Novel -Acylhydrazone Derivatives of Pyrrolo[3,4-]pyridazinone as Dual COX/LOX Inhibitors.新型吡咯并[3,4-d]哒嗪酮 - 酰腙衍生物作为 COX/LOX 双重抑制剂的合成、生物、光谱和计算研究。
Molecules. 2023 Jul 18;28(14):5479. doi: 10.3390/molecules28145479.
5
Can Nonsteroidal Anti-Inflammatory Drugs Lead to First-Time Heart Failure in Patients with Diabetes Mellitus Type-2: Is There a Link?非甾体抗炎药会导致2型糖尿病患者首次发生心力衰竭吗：存在关联吗？
Pharmacology. 2023;108(5):492-494. doi: 10.1159/000531604. Epub 2023 Jul 27.
6
Targeting EP2 Receptor for Drug Discovery: Strengths, Weaknesses, Opportunities, and Threats (SWOT) Analysis.针对 EP2 受体的药物发现：优势、劣势、机会和威胁（SWOT）分析。
J Med Chem. 2023 Jul 27;66(14):9313-9324. doi: 10.1021/acs.jmedchem.3c00655. Epub 2023 Jul 17.
7
Design, Synthesis, Biological Evaluation, and Molecular Docking Study of 4,6-Dimethyl-5-aryl/alkyl-2-[2-hydroxy-3-(4-substituted-1-piperazinyl)propyl]pyrrolo[3,4-]pyrrole-1,3(2,5)-diones as Anti-Inflammatory Agents with Dual Inhibition of COX and LOX.4,6-二甲基-5-芳基/烷基-2-[2-羟基-3-(4-取代-1-哌嗪基)丙基]吡咯并[3,4-c]吡咯-1,3(2,5)-二酮作为具有COX和LOX双重抑制作用的抗炎剂的设计、合成、生物学评价及分子对接研究
Pharmaceuticals (Basel). 2023 May 29;16(6):804. doi: 10.3390/ph16060804.
8
Targeting Nociceptive Neurons and Transient Receptor Potential Channels for the Treatment of Migraine.针对伤害感受神经元和瞬时受体电位通道治疗偏头痛。
Int J Mol Sci. 2023 Apr 26;24(9):7897. doi: 10.3390/ijms24097897.
9
Interactions of -Mannich Bases of Pyrrolo[3,4-]pyrrole with Artificial Models of Cell Membranes and Plasma Proteins, Evaluation of Anti-Inflammatory and Antioxidant Activity.吡咯并[3,4 - ]吡咯的β - 曼尼希碱与细胞膜和血浆蛋白人工模型的相互作用、抗炎和抗氧化活性评估
Membranes (Basel). 2023 Mar 17;13(3):349. doi: 10.3390/membranes13030349.
10
Temporal Expression of Neuroinflammatory and Oxidative Stress Markers and Prostaglandin E2 Receptor EP2 Antagonist Effect in a Rat Model of Epileptogenesis.神经炎症和氧化应激标志物的时间表达以及前列腺素E2受体EP2拮抗剂在癫痫发生大鼠模型中的作用
ACS Pharmacol Transl Sci. 2022 Dec 8;6(1):128-138. doi: 10.1021/acsptsci.2c00189. eCollection 2023 Jan 13.